LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.21 | 17.25 | 2426 | 4942 | 0.4909 | 0.8330 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.21 | 17.25 | 2585 | 4942 | 0.5230 | 0.8473 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.21 | 17.25 | 3312 | 4942 | 0.6701 | 0.9043 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.21 | 17.25 | 3336 | 4942 | 0.6750 | 0.9060 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.21 | 17.25 | 18 | 4942 | 0.0036 | 0.0052 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 58.21 | 17.25 | 3505 | 4942 | 0.7092 | 0.9175 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 60.18 | 17.25 | 2592 | 5031 | 0.5152 | 0.8444 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 60.18 | 17.25 | 2696 | 5031 | 0.5358 | 0.8533 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 60.18 | 17.25 | 3509 | 5031 | 0.6974 | 0.9139 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 60.18 | 17.25 | 3535 | 5031 | 0.7026 | 0.9156 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 60.18 | 17.25 | 19 | 5031 | 0.0038 | 0.0119 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 60.18 | 17.25 | 3738 | 5031 | 0.7429 | 0.9287 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.15 | 17.25 | 2899 | 5061 | 0.5728 | 0.8686 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.15 | 17.25 | 2960 | 5061 | 0.5849 | 0.8733 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.15 | 17.25 | 3745 | 5061 | 0.7400 | 0.9279 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.15 | 17.25 | 3782 | 5061 | 0.7473 | 0.9302 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.15 | 17.25 | 18 | 5061 | 0.0036 | 0.0052 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.15 | 17.25 | 3929 | 5061 | 0.7763 | 0.9392 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 65.12 | 17.25 | 3100 | 5095 | 0.6084 | 0.8825 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 65.12 | 17.25 | 3166 | 5095 | 0.6214 | 0.8873 | MN20160310_N02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 65.12 | 17.25 | 3981 | 5095 | 0.7813 | 0.9408 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 65.12 | 17.25 | 4023 | 5095 | 0.7896 | 0.9432 | MN20160310_N02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 65.12 | 17.25 | 17 | 5095 | 0.0033 | -0.0018 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 65.12 | 17.25 | 4192 | 5095 | 0.8227 | 0.9530 | MN20160310_N02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 67.09 | 17.25 | 3337 | 5221 | 0.6392 | 0.8943 | MN20160310_N02 | C10 |